Veloso D, Campbell G
Division of Medicine, USAMRIID, Frederick, MD 21702-5011.
Agents Actions Suppl. 1992;38 ( Pt 1):166-73. doi: 10.1007/978-3-0348-7321-5_22.
The distribution of prekallikrein and the complexes of kallikrein with C1 inhibitor (C1INH), alpha 2-macroglobulin and approximately 58-kDa protein(s) (e.g. antithrombin III), differs in normal and C1INH-deficient human plasma, activated in vitro, due to different C1INH levels. Different distribution in the deficient plasma activated in vivo or in vitro, suggests different rates of complex clearance.